title: Looking through the vascular normalization window: timing antiangiogenic treatment and chemotherapy with (99m)Tc-annexin A5.
authors: Michael R
authors: MR
authors: Lewis
mesh_terms: D000818:Animals; D017304:Annexin A5; D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D000068258:Bevacizumab; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000494:pharmacology; D015179:Colorectal Neoplasms / Q000098:blood supply*; D005260:Female; D000077146:Irinotecan; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D015609:Organotechnetium Compounds; D015899:Tomography, Emission-Computed, Single-Photon
chemical_list: C568748:(99)mTc-(CO)(3) His-annexin A5; D017304:Annexin A5; D061067:Antibodies, Monoclonal, Humanized; D015609:Organotechnetium Compounds; D000068258:Bevacizumab; D000077146:Irinotecan; D002166:Camptothecin